TickerFacts.

Mangoceuticals, Inc. (MGRX): Operating Income

Annual figures by period end, from SEC filings.

-$18.03M
Year ended 2025-12-31
-$12.07M
Trailing 12 months to 2026-06-30
2022-12-31: -$1.99M2023-12-31: -$9.22M2024-12-31: -$7.97M2025-12-31: -$18.03M-$18.03M
2022-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$18.03Mn/m2026-04-01, From 2025-01-01
2024-12-31-$7.97Mn/m2026-04-01, From 2024-01-01
2023-12-31-$9.22Mn/m2025-03-20, From 2023-01-01
2022-12-31-$1.99Mn/a2024-04-01, From 2022-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Mangoceuticals, Inc. (MGRX)2025-12-31-$18.03Mn/m
BioRestorative Therapies, Inc. (BRTX)2025-12-31-$15.65Mn/m
Charming Medical Ltd (MCTA)2026-03-31-$29.2Kn/m
Pacific Health Care Organization Inc (PFHO)2025-12-31$1.00M+17.4%
Marpai, Inc. (MRAI)2025-12-31-$13.55Mn/m
Cryo Cell International Inc (CCEL)2025-11-30$482.4K-86.1%
Viemed Healthcare, Inc. (VMD)2025-12-31$22.95M+28.2%
Sotera Health Co (SHC)2024-12-31$297.63M+7.6%
Progyny, Inc. (PGNY)2025-12-31$85.28M+26.4%

Compare MGRX, BRTX, MCTA, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗